SCHEMBL29475702

SCHEMBL29475702

CC(C)[C@H](NC(=O)CCOCCON1C(=O)c2ccccc2C1=O)C(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.44
▸ KLK5 Q9Y337 1/20 0.39
▸ CYP1A2 P05177 2/20 0.37
▸ SDCBP O00560 1/20 0.35
▸ SDC2 P34741 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CYP2C9 P11712 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ IL1RN P18510 1/20 0.34
▸ ERAP2 Q6P179 1/20 0.34
▸ ERAP1 Q9NZ08 1/20 0.34
▸ MALT1 Q9UDY8 1/20 0.33
▸ REN P00797 1/20 0.33
▸ CTSD P07339 1/20 0.33
▸ FNTA P49354 1/20 0.33
▸ FNTB P49356 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26347018 1.00 GAA (0.49) GAAALDH1A1KLK5CYP1A2SDCBP
SCHEMBL30503471 1.00 GAA (0.49) GAAALDH1A1KLK5CYP1A2SDCBP
SCHEMBL26347009 0.86 GAA (0.55) GAAALDH1A1CYP1A2SDCBPSDC2
SCHEMBL29475669 0.86 GAA (0.55) GAAALDH1A1CYP1A2SDCBPSDC2
SCHEMBL28656285 0.86 GAA (0.55) GAAALDH1A1CYP1A2SDCBPSDC2
SCHEMBL22347082 0.84 GAA (0.49) GAAALDH1A1CYP1A2CYP2C9RECQL
SCHEMBL14950485 0.79 GAA (0.63) GAAALDH1A1CYP1A2KMT2ACYP2C9
SCHEMBL16726882 0.79 GAA (0.63) GAAALDH1A1CYP1A2KMT2ACYP2C9
SCHEMBL25719625 0.74 GAA (0.58) GAAALDH1A1MALT1
SCHEMBL21792191 0.73 ALDH1A1 (0.47) GAAALDH1A1KLK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119455003-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 — — CN disclosed
CN-119455004-A Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2025-02-18 — — CN disclosed
CN-113660957-B Compositions, methods and uses comprising antibody-TLR agonist conjugates AMBRX公司 2024-12-13 — — CN disclosed
EP-4199968-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF Ambrx, Inc. (US) 2023-06-28 — — EP disclosed
WO-2022040596-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF AMBRX, INC. (US) 2022-02-24 — — WO disclosed
Send feedback